Fruits and veggies not likely linked to colon cancer risk

Sep 25, 2007

Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the September 25 Journal of the National Cancer Institute.

Several studies have examined the relationship between colon cancer and fruit and vegetable intake, but the results have been inconsistent. A team of researchers led by Anita Koushik, Ph.D., formerly of the Harvard School of Public Health in Boston, analyzed the association between fruit and vegetable intake and colon cancer risk by pooling the results of 14 studies that included 756,217 men and women who were followed for 6 to 20 years.

Their analysis showed that while fruit and vegetable intake was not strongly associated with overall colon cancer risk, there may be a lower risk of cancer of the distal colon—the left-hand side of the colon—among those who consumed the largest amounts of fruits and vegetables. However, the difference in the associations for cancers on the left and right sides was not statistically significant.

“Results for each fruit and vegetable group were generally consistent between men and women,” the authors write.

Source: Journal of the National Cancer Institute

Explore further: Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer

add to favorites email to friend print save as pdf

Related Stories

Maximizing broccoli's cancer-fighting potential

Oct 16, 2013

Spraying a plant hormone on broccoli—already one of the planet's most nutritious foods—boosts its cancer-fighting potential, and researchers say they have new insights on how that works. They published ...

Taste perception of bitter foods depends on genetics

Apr 04, 2011

(PhysOrg.com) -- How we perceive the taste of bitter foods -- and whether we like or dislike them, at least initially -- depends on which versions of taste-receptor genes a person has, according to a researcher ...

Recommended for you

70-gene signature not cost-effective in breast cancer

Oct 18, 2014

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

User comments : 0